Hemangiosarcoma in cats: treatment, prognosis and clinical trials
Cats · USA & Canada
Understanding hemangiosarcoma
Feline hemangiosarcoma is a cancer of blood-vessel-forming cells and is uncommon. It can occur in the skin, under the skin or in internal organs such as the spleen. Superficial disease may behave differently from visceral disease, which can bleed and spread, so location is a major part of the diagnosis.
What does the prognosis look like?
Complete removal may give long control for some tumors confined to the surface of the skin. Visceral disease is very different: in a 26-cat study, the typical survival time was about 2–3 months among the six cats that survived the immediate diagnostic period; a newer splenectomy group had a typical time of about 3 months. These small, selected groups do not predict an individual cat and should never be applied to a completely removed skin tumor.
What matters next
First separate a skin or subcutaneous tumor from visceral disease and determine whether there is bleeding or spread. Collapse, pale gums, weakness, breathing difficulty or suspected internal bleeding can require urgent care. A completely removable skin lesion and multifocal visceral hemangiosarcoma should not be approached as the same situation.
Where are you now?
There is internal bleeding or suspected rupture
Pale gums, collapse, marked weakness, a distended abdomen, or breathing difficulty can be urgent. Stabilization and control of bleeding come before the long-term cancer plan.
The tumor was already removed
Review the exact primary site, pathology, margins, and staging. Feline hemangiosarcoma behavior differs by site, so a superficial cutaneous tumor and visceral disease should not be given the same expectations.
Visceral or metastatic disease is present
Systemic evidence in cats is limited. Focus the discussion on the sites causing clinical problems, realistic treatment goals, and whether any systemic option has feline-specific support.
If you are waiting for oncology
If disease is visceral, monitor urgently for bleeding, weakness or collapse. If it is cutaneous or subcutaneous, prognosis and treatment may be very different, so establish the anatomic form before borrowing expectations from canine visceral disease.
Questions to ask your oncologist
- Is this superficial or visceral hemangiosarcoma?
- Is there active bleeding or disease elsewhere?
- What feline evidence supports any systemic treatment being proposed?
How the diagnosis may appear in the record
The record should distinguish cutaneous, subcutaneous, splenic, cardiac, hepatic, or other visceral disease because feline evidence is limited and these forms do not share one outlook. An internal mass on imaging is not a confirmed hemangiosarcoma until tissue establishes the diagnosis.
Changes to watch for at home
Collapse, pale gums, sudden weakness, a swollen abdomen, rapid breathing, or breathing distress can indicate internal bleeding or fluid around the heart and is urgent. After surgery, report new weakness or pallor promptly. A superficial skin lesion does not carry the same immediate bleeding risk as visceral disease.
How it is usually treated
Complete surgery is the main local treatment for resectable disease. Superficial skin tumors can behave very differently from visceral hemangiosarcoma. For internal or disseminated disease, systemic treatment may be discussed, but feline evidence is limited and the plan should be individualized.
What can affect treatment choices
Cutaneous versus subcutaneous versus visceral disease, active bleeding, resectability and visible spread shape the plan. The limited feline evidence for systemic therapy also matters when weighing treatment.
Tests that may matter
CBC and chemistry help identify anemia and organ effects. Abdominal imaging and chest staging are useful for visceral disease, but imaging may not show every microscopic or multifocal lesion. Pathology, and sometimes immunohistochemistry, confirms the diagnosis.